Prediction: 1 Dirt Cheap Warren Buffett Stock That Will Be Worth More Than Palantir By 2030

Palantir Technologies - Palantir has experienced a significant stock rally, with shares increasing by 130% in 2025, benefiting from the surge in artificial intelligence (AI) spending [1][4] - The company's AI-powered software suite, including Foundry, Apollo, and Gotham, has seen exponential demand from both government and private sectors [4][6] - Despite strong business performance, concerns arise regarding Palantir's high valuation, with a price-to-sales (P/S) ratio of 114, which is significantly higher than its peers [10][11] - The current valuation multiples exceed those seen during the dot-com bubble, raising concerns about a potential correction in the stock price [12][13] UnitedHealth Group - UnitedHealth Group's stock has declined by 36% this year, making it the worst performer in the Dow Jones Industrial Average [2] - The decline was primarily due to a reduction in financial guidance, influenced by higher-than-expected costs and lower engagement in certain markets [14][16] - Despite the downturn, the company's price-to-earnings (P/E) ratio of 16.8 is near five-year lows, suggesting that the stock may be undervalued [14][19] - Insider buying, including purchases by Warren Buffett, indicates confidence in a potential turnaround for UnitedHealth [17][20] - The company may benefit from AI advancements, which could enhance operational efficiency and forecasting capabilities [16][20]